Incyte to Present at Upcoming Investor Conferences

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq: INCY) announced today that it will present at the following investor conferences during the month of September:

• Morgan Stanley Global Healthcare Conference on Wednesday, September 14, 2016 at 11:05 am (EDT) in New York; and
• LEERINK Partners Rare Disease & Immuno-Oncology Roundtable on Thursday, September 29, 2016 at 3:45 pm (EDT) in New York

The presentations will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations”. Investors interested in listening to the live webcasts should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company's web site at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160830005003/en/

Incyte Corporation
Media
Catalina Loveman, +1 302-498-6171
[email protected]
or
Investors
Michael Booth, DPhil, +1 302-498-5914
[email protected]

Source: Incyte Corporation

You May Also Be Interested In

• Incyte (INCY) PT Lowered to $84 at Oppenheimer
• Incyte (INCY) PT Lowered to $64 at BofA Securities
• Incyte Announces Acquisition of Escient Pharmaceuticals and its Pipeline of First-in-Class Oral MRGPR Antagonists